FDA approves new drug to treat autoimmune liver disease: ‘Giant step forward’
Fox News
The U.S. Food and Drug Administration has approved the French drugmaker Ipsen’s medication Iqirvo (elafibranor). Doctors discuss what this means for liver disease patients.
"It is distressing to know that your body is fighting itself and you can’t figure out how to stop it." Primary biliary cholangitis affects approximately 100,000 people in the U.S. Amy McGorry is a contributing health writer for Fox News Digital. Follow her on Twitter @amymcgorry.
The drug, an 80 mg tablet administered orally once daily, is intended to treat an autoimmune cholestatic liver disease called primary biliary cholangitis (PBC).
More Related News